PROTAC Market Expansion Driven by Growing Demand for Targeted Protein Degradation Therapies
Proteolysis Targeting Chimeras (PROTACs) represent a revolutionary therapeutic approach in drug development, combining protein degradation technology with targeted disease treatment. These bifunctional molecules are designed to selectively eliminate disease-causing proteins by facilitating their degradation through the cell's natural protein disposal system. PROTACs offer several advantages...
0 Kommentare 0 Geteilt 8 Ansichten 0 Bewertungen
Gesponsert